< Back to companies
Endofotonics

Endofotonics

Singapore, Singapore

Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients. Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2013
Website
m.endofotonics.com/

Categories

Cancer

Disease Areas

Technologies

PlatformDiagnostic DevicesMedical Technology
Only accessible to MedStartr community members. Join now

What do you think of Endofotonics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now